DGX: Organic growth, consumer health, and partnerships drive strong results amid regulatory uncertainty

Revenue and earnings growth have outpaced long-range plans, driven by organic expansion, strategic partnerships, and a booming consumer health segment. Integration of major deals and disciplined M&A remain priorities, while regulatory uncertainty around PAMA persists.Based on Quest Diagnostics Inco…